Publication | Closed Access

Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells

Intermittent TreatmentMetabolic SyndromeMedicinePhysiologyPth1 Receptor InhibitsParathyroid HormoneParathyroid DiseaseParathyroid GlandOsteoporosisEndocrinologyPharmacologyCell BiologyCell SignalingHealth Sciences